Cargando…
Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A Retrospective Cohort Study
(1) Background: The efficacy of tocilizumab in COVID-19 has been doubted. The study aimed to investigate factors affecting disease stability and response to tocilizumab among severe COVID-19 patients. (2) Methods: This was a cohort study of 70 severe COVID-19 patients at NMC Royal Hospital, UAE, fro...
Autores principales: | Hafez, Wael, Abdelrahman, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405062/ https://www.ncbi.nlm.nih.gov/pubmed/36009949 http://dx.doi.org/10.3390/antibiotics11081078 |
Ejemplares similares
-
Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study
por: Hafez, Wael, et al.
Publicado: (2022) -
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
por: Guaraldi, Giovanni, et al.
Publicado: (2020) -
Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study
por: Kewan, Tariq, et al.
Publicado: (2020) -
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2022) -
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study
por: KÜÇÜKŞAHİN, Orhan, et al.
Publicado: (2022)